ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2026
Sensitivity profile of tolerant and persistent Staphylococcus spp. from goat mastitis to Jatobá (Hymenaea martiana Hayne) extract.
Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The aim of this study was to evaluate the effect of the crude ethanolic extract (CEE) from the bark of H. martiana Hayne on tolerant and persistent Staphylococcus spp. isolates from goat mastitis. The H. martiana extract was obtained from the bark, secondary metabolites were identified by high-performance liquid chromatography (HPLC). The virulence of the isolates was evaluated through efflux pump, molecular docking, and biofilm assays, while their resistance profile was assessed using antimicrobial sensitivity, synergism, and kill curve tests. The presence of the major compounds astilbin and engelitin was verified and the Staphylococcus spp. isolates showed sensitivity to the CEE at a minimum concentration of 390.6 µg ml− 1. The compounds astilbin and engelitin showed better target binding energy compared to enrofloxacin. In virulence assays, the isolates did not exhibit an efflux pump and had a weak biofilm-forming capacity. Potential CCE activity against these structures was observed, warranting further investigation. In the synergistic assay, CCE reduced the minimum inhibitory concentration of enrofloxacin sevenfold, to a concentration of 0.124 µg ml− 1. Persistent subpopulations were not eliminated during Persistent subpopulations were not eliminated during the 10-hour evaluation period, suggesting a need for a longer study. In conclusion, CCE from H. martiana shows therapeutic potential for goat mastitis caused by Staphylococcus spp..
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.